Displaying drugs 14901 - 14925 of 15136 in total
Imdusiran
Imdusiran is under investigation in clinical trial NCT06245291 (Study of Imdusiran (AB-729) in Combination With Intermittent Dosing of Durvalumab in Subjects With Chronic HBV Infection).
Investigational
DAS869
Experimental
LI-301
LI 301 is an orally bio-available compound delivered in a fast melt mechanism with taste masking enabling it to be taken anytime without water. It has a novel mode of action combining both the light effect of a Selective Serotonin Reuptake Inhibitor ("SSRI")(most likely antagonistic at 5HT1a receptors) and antagonism...
Investigational
Matched Description: … of a Selective Serotonin Reuptake Inhibitor ("SSRI")(most likely antagonistic at 5HT1a receptors) and …
A-98881
Experimental
CCT-018159
Experimental
CRA-9334
Experimental
CRA_9785
Experimental
6-Methylamino-5-Nitroisocytosine
Experimental
CRA_1802
Experimental
Displaying drugs 14901 - 14925 of 15136 in total